CORRECTING and REPLACING Elizabeth Arden, Inc. Announces Second Quarter Fiscal 2013 Results
2013-02-04 14:06 ET - News Release
~ Net Sales of $468 Million; Increase of 9% ~ ~ Adjusted EPS of $1.58; Increase of 11% ~ ~ Fiscal Year-to-Date Net Sales Increase of 11%; Adjusted EPS
Increase of 17% ~ NEW YORK -- (Business Wire)
A correction was made to the "Segment Net Sales" table in the release
dated January 31, 2012. In the "Three Months Ended" section, the "%
Increase/(Decrease)" figures were corrected.
The corrected release reads:
ELIZABETH ARDEN, INC. ANNOUNCES SECOND QUARTER FISCAL 2013 RESULTS ~ Net Sales of $468 Million; Increase of 9% ~ ~ Adjusted EPS of $1.58; Increase of 11% ~ ~ Fiscal Year-to-Date Net Sales Increase of 11%; Adjusted EPS
Increase of 17% ~
Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products
company, today announced financial results for its second fiscal quarter
ended December 31, 2012.
SECOND QUARTER RESULTS
For the quarter ended December 31, 2012, the Company reported net sales
of $467.9 million, an increase of 8.8% as compared to the second quarter
of the prior fiscal year. Excluding the unfavorable impact of foreign
currency translation, net sales increased by 9.1%.
On a reported basis, net income per diluted share for the current year
period was $1.47. On an adjusted basis, net income per diluted share for
the quarter ended December 31, 2012 was $1.58, as compared to net income
per diluted share of $1.42 for the prior year period. Adjusted net
income per diluted share excludes acquisition-related expenses and
non-recurring charges associated with the Elizabeth Arden brand
repositioning. A reconciliation between GAAP and adjusted results can be
found in the tables and footnotes at the end of this press release.
In North America, net sales increased 8.4% for the quarter and 13%
fiscal year-to-date. The Company's fragrance portfolio continued to add
market share, with both prestige and mass retailers gaining 2.15% and
2.1%, respectively. Sales growth was driven by the recently acquired
brands, new launches, including Justin Bieber's Girlfriend, Pink
Friday Nicki Minaj and Taylor Swift Wonderstruck Enchanted,
which all ranked among the top fragrance launches in U.S. prestige
department stores for the holiday season, and growth in existing pillar
fragrance brands. Performance at prestige retailers was strong with a
number of the Company's key existing brands as well, with the largest
retail sales increases posted by the Juicy Couture, John
Varvatos and Curve fragrances. Net sales of Elizabeth Arden
branded products decreased 6% for the quarter and 6.5% fiscal
year-to-date in North America. In terms of retail sales, overall retail
sales at Elizabeth Arden counters in North America were flat, with the
Company's recently converted Elizabeth Arden flagship counters
increasing 24% year over year since conversion through the end of
December.
Internationally, net sales grew 11% (constant rates) for the second
fiscal quarter and 10% (constant rates) fiscal year-to-date. Net sales
of fragrances increased 14% (constant rates) for the first six months,
behind the Company's Western European fragrance initiative. As a result,
fragrance sales in Europe grew 18% (constant rates) during the same
period. Net sales of Elizabeth Arden branded products grew 10% (constant
rates) for the second quarter and 7% (constant rates) for the first half
of the fiscal year. As for retail sales performance, retail sales of
Elizabeth Arden products at international flagship doors increased by 9%
since conversion, reflecting later conversion dates as compared to the
flagship doors in North America.
E. Scott Beattie, Chairman, President and Chief Executive Officer of
Elizabeth Arden, Inc., commented, "Second quarter sales and earnings
were up solidly from the prior year, with strong retail sales
performance within our North America and International businesses.
Nonetheless, our net sales results were below original guidance due to
lower than forecasted sales in department stores as well as softer than
anticipated holiday sales at one of our major mass retail accounts.
Despite strong sales growth among many of our global affiliates,
international net sales were impacted by lower than expected inventory
replenishment in our travel retail business and weakness in Greater
China."
Mr. Beattie continued, "Over the course of the past few months, we
successfully completed the conversion of our Elizabeth Arden flagship
doors and are very excited with the momentum of sales increases. The
flagship model was established as a way for us to test, learn, and
gather feedback on the repositioning of the Elizabeth Arden brand as
well as build confidence in the growth potential of the brand with our
key retail partners. Flagship counters in the North American markets
were converted earlier this fall, with all door conversions complete by
the end of October. U.S. flagship doors delivered 24% year-over-year
retail sales growth from conversion through the end of December, well in
excess of the U.S. prestige category which grew 5% for the second
quarter.
"The timing of the conversion of international flagship doors was
staggered across the quarter due to retailer constraints. International
flagship doors delivered 9% retails sales growth from conversion,
reflecting later conversion dates as compared to the flagship doors in
North America, and are gaining momentum by the week. The most recent
weeks have achieved retail sales growth of 23%. Given our early success,
we plan to extend key elements of the flagship model to the next tier of
approximately 200 doors globally during the remainder of fiscal 2013 and
drive sales growth behind the roll out of new products for our
international markets during the second half of the fiscal year."
SIX MONTH RESULTS
For the six months ended December 31, 2012, the Company reported net
sales of $812.5 million, an increase of 10.8%, as compared to the prior
year period. Excluding the unfavorable impact of foreign currency
translation, net sales increased by 12%. On a reported basis, net income
per diluted share for the six months ended December 31, 2012 was $1.54.
On an adjusted basis, net income per diluted share was $2.02, as
compared to net income per diluted share of $1.73 for the prior year
period. Adjusted net income per diluted share excludes
acquisition-related expenses and non-recurring charges associated with
the Elizabeth Arden brand repositioning. A reconciliation between GAAP
and adjusted results can be found in the tables and footnotes at the end
of this press release.
OUTLOOK
Based on the retail trends year-to-date and the seasonally slower
fragrance market in the second fiscal half, the Company is reducing its
second half revenue and earnings guidance. For the full fiscal year
ending June 30, 2013, the Company currently expects net sales to
increase by 9% to 11%, assuming an expected unfavorable impact from
foreign currency of approximately 0.5%, as compared to the prior year
period, and for earnings per diluted share (adjusted) to be in the range
of $2.30 to $2.50. The Company currently expects gross margin (adjusted)
for fiscal 2013 to increase by 75 to 100 basis points as compared to
gross margin (adjusted) for fiscal 2012.
For the third quarter of fiscal 2013, the Company is introducing
guidance for net sales of $255 million to $270 million, and for net
income per diluted share of $0.00 to $0.04. The net sales guidance for
the third quarter of fiscal 2013 assumes an unfavorable impact from
foreign currency rates of approximately 0.2%, as compared to rates in
effect for the prior year period.
The earnings guidance excludes non-recurring charges related to the
Elizabeth Arden brand repositioning and expenses related to the
acquisitions completed in the fourth quarter of fiscal 2012. The Company
expects to incur the remainder of these charges, currently estimated at
$4.3 million (pre-tax), primarily in the third quarter of fiscal 2013.
The guidance is based on current foreign currency rates. The Company
also notes that continued global economic uncertainty may have a
negative effect on retailer and consumer confidence and demand, and,
along with the foreign currency volatility, makes forecasting difficult.
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 9:30 a.m. Eastern Time.
All interested parties can listen to a live web cast of the Company's
conference call by visiting the Investor Relations section of the
Corporate tab on the Company's web site at http://ir.elizabetharden.com.
An online archive of the broadcast will be available within one hour of
the completion of the call and will be accessible on the Company's web
site until March 1, 2013.
Elizabeth Arden is a global prestige beauty products company with an
extensive portfolio of prestige beauty brands sold in over 120
countries. The company's brand portfolio includes Elizabeth Arden
skincare, color and fragrance products, the celebrity fragrance brands
of Britney Spears, Elizabeth Taylor, Justin Bieber, Mariah Carey, Nicki
Minaj, Taylor Swift, and Usher; the designer fragrance brands of Juicy
Couture, Alfred Sung, BCBGMAXAZRIA, Geoffrey Beene, Halston, Ed Hardy,
John Varvatos, Kate Spade, Lucky Brand, True Religion and Rocawear; and
the lifestyle fragrance brands Curve, Giorgio Beverly Hills, and PS Fine
Cologne.
|
| |
| ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF INCOME DATA
(Unaudited)
(In thousands, except percentages and per share data) | | |
|
|
| |
|
| | | | | | | Three Months Ended | | | Six Months Ended | | | | | | December 31, |
| December 31, | | | December 31, |
| December 31, | | | | | | 2012 | | 2011 |
| | | 2012 | | 2011 | | |
Net Sales
| | | |
$
|
467,919
| | |
$
|
429,926
| | | |
$
|
812,460
| | |
$
|
733,460
| | | | | | | | | | | | | | |
| |
Cost of Goods Sold:
| | | | | | | | | | | | | |
Cost of Sales
| | | | |
229,966
| | | |
211,012
| | | | |
425,577
| | | |
370,767
| | | |
Depreciation Related to Cost of Goods Sold
| | | |
|
1,487
|
| |
|
1,601
|
| | |
|
3,018
|
| |
|
2,944
|
| | |
Total Cost of Goods Sold
| | | | |
231,453
| | | |
212,613
| | | | |
428,595
| | | |
373,711
| | | | | | | | | | | | | | |
| |
Gross Profit
| | | | |
236,466
| | | |
217,313
| | | | |
383,865
| | | |
359,749
| | | |
Gross Profit Percentage
| | | | |
50.5
|
%
| | |
50.5
|
%
| | | |
47.2
|
%
| | |
49.0
|
%
| | | | | | | | | | | | | |
|
Selling, General and Administrative Expenses
| | | | |
163,253
| | | |
148,451
| | | | |
292,660
| | | |
266,898
| | | |
Depreciation and Amortization
| | | |
|
9,372
|
| |
|
7,070
|
| | |
|
18,501
|
| |
|
13,788
|
| | |
Total Operating Expenses
| | | | |
172,625
| | | |
155,521
| | | | |
311,161
| | | |
280,686
| | | | | | | | | | | | | | |
| |
Interest Expense, Net
| | | | |
6,424
| | | |
5,786
| | | | |
12,622
| | | |
11,048
| | | | | | | | | | | | | | |
| |
Income Before Income Taxes
| | | | |
57,417
| | | |
56,006
| | | | |
60,082
| | | |
68,015
| | | |
Provision for Income Taxes
| | | |
|
12,608
|
| |
|
13,635
|
| | |
|
13,089
|
| |
|
16,412
|
| | |
Net Income
| | | |
$
|
44,809
|
| |
$
|
42,371
|
| | |
$
|
46,993
|
| |
$
|
51,603
|
| | | | | | | | | | | | | |
| As reported: | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Net Income Per Basic Share
| | | |
$
|
1.51
| | |
$
|
1.46
| | | |
$
|
1.59
| | |
$
|
1.78
| | | |
Net Income Per Diluted Share
| | | |
$
|
1.47
| | |
$
|
1.42
| | | |
$
|
1.54
| | |
$
|
1.73
| | | | | | | | | | | | | | |
| |
Basic Shares
| | | | |
29,680
| | | |
28,980
| | | | |
29,617
| | | |
28,925
| | | |
Diluted Shares
| | | | |
30,492
| | | |
29,917
| | | | |
30,498
| | | |
29,913
| | | | | | | | | | | | | | |
| |
EBITDA (a)
| | | |
$
|
74,700
| | |
$
|
70,463
| | | |
$
|
94,223
| | |
$
|
95,795
| | | |
EBITDA margin (a)
| | | | |
16.0
|
%
| | |
16.4
|
%
| | | |
11.6
|
%
| | |
13.1
|
%
| | | | | | | | | | | | | |
|
Adjusted to exclude acquisition-related and
Elizabeth Arden repositioning costs, net of
taxes (b)(c):
| | | | | | | | | | | | | | | | |
| | | | | | | | | |
Gross Profit
| | | |
$
|
241,898
| | |
$
|
217,313
| | | |
$
|
404,017
| | |
$
|
359,749
| | | |
Gross Profit Percentage
| | | | |
51.7
|
%
| | |
50.5
|
%
| | | |
49.7
|
%
| | |
49.0
|
%
| | | | | | | | | | | | | |
| |
Net Income
| | | |
$
|
48,057
| | |
$
|
42,371
| | | |
$
|
61,498
| | |
$
|
51,603
| | | | | | | | | | | | | | |
| |
Net Income Per Basic Share
| | | |
$
|
1.62
| | |
$
|
1.46
| | | |
$
|
2.08
| | |
$
|
1.78
| | | |
Net Income Per Diluted Share
| | | |
$
|
1.58
| | |
$
|
1.42
| | | |
$
|
2.02
| | |
$
|
1.73
| | | | | | | | | | | | | | |
| |
EBITDA (a)
| | | |
$
|
80,514
| | |
$
|
70,463
| | | |
$
|
115,101
| | |
$
|
95,795
| | | |
EBITDA margin (a)
| | | | |
17.2
|
%
| | |
16.4
|
%
| | | |
14.2
|
%
| | |
13.1
|
%
| | | | | | | | | | | | | |
|
(a) EBITDA is defined as net income plus the provision for income taxes
plus interest expense, plus depreciation and amortization. EBITDA should
not be considered as an alternative to income from operations or net
income (as determined in accordance with generally accepted accounting
principles (GAAP)) as a measure of our operating performance or to net
cash provided by operating, investing and financing activities (as
determined in accordance with GAAP) or as a measure of our ability to
meet cash needs. We believe that EBITDA is a measure commonly reported
and widely used by investors and other interested parties as a measure
of a company's operating performance and debt servicing ability because
it assists in comparing performance on a consistent basis without regard
to capital structure, depreciation and amortization or non-operating
factors (such as historical cost). Accordingly, as a result of our
capital structure, we believe EBITDA is a relevant measure. This
information has been disclosed here to permit a more complete
comparative analysis of our operating performance relative to other
companies and of our debt servicing ability. EBITDA may not, however, be
comparable in all instances to other similar types of measures. We have
also disclosed EBITDA as adjusted without giving effect to
acquisition-related and Elizabeth Arden repositioning costs. This
disclosure is being provided for comparability purposes because we
believe it is meaningful to our investors and other interested parties
to understand the EBITDA performance of the Company on a consistent
basis without regard to the effect of acquisition-related and Elizabeth
Arden repositioning costs.
The table below reconciles net income, as determined in accordance with
GAAP, to EBITDA and to EBITDA as adjusted: (For a reconciliation of net
income to EBITDA for prior periods, see the Company's filings with the
Securities and Exchange Commission which can be found on the Company's
website at www.elizabetharden.com.)
|
|
|
| (In thousands) |
|
|
| Three Months Ended |
|
| Six Months Ended | | | | | | | | | December 31, 2012 |
| December 31, 2011 | | | December 31, 2012 |
| December 31, 2011 | | | | |
Net income
| | | |
$
|
44,809
| |
$
|
42,371
| | |
$
|
46,993
| |
$
|
51,603
| | | | |
Plus:
| | | | | | | | | | | | | | | |
Provision for income taxes
| | | | |
12,608
| | |
13,635
| | | |
13,089
| | |
16,412
| | | | |
Interest expense, net
| | | | |
6,424
| | |
5,786
| | | |
12,622
| | |
11,048
| | | | |
Depreciation related to cost of goods sold
| | | | |
1,487
| | |
1,601
| | | |
3,018
| | |
2,944
| | | | |
Depreciation and amortization
| | | |
|
9,372
| |
|
7,070
| | |
|
18,501
| |
|
13,788
| | | | |
EBITDA
| | | | |
74,700
| | |
70,463
| | | |
94,223
| | |
95,795
| | | | |
Acquisition-related and Elizabeth Arden repositioning costs
(c)
| | | |
|
5,814
| |
|
--
| | |
|
20,878
| |
|
--
| | | | |
EBITDA as adjusted
| | | |
$
|
80,514
| |
$
|
70,463
| | |
$
|
115,101
| |
$
|
95,795
| | | | | | | | | | | | | | | | | | | | |
|
The table below reconciles net cash flow (used in) provided by operating
activities, as determined in accordance with GAAP, to EBITDA:
|
|
|
| |
|
|
|
|
| | | | | | (Amounts in thousands) | | | | | | Six Months Ended | | | | | | | | | | | December 31, 2012 |
|
| December 31, 2011 | | | | |
Net cash (used in) provided by operating activities
| | | | | |
$
|
(10,888
|
)
| | |
$
|
49,169
| | | | | |
Changes in assets and liabilities, net of acquisitions
| | | | | | |
92,306
| | | | |
35,998
| | | | | |
Interest expense, net
| | | | | | |
12,622
| | | | |
11,048
| | | | | |
Amortization of senior note offering and credit facility costs
| | | | | | |
(682
|
)
| | | |
(621
|
)
| | | | |
Provision for income taxes
| | | | | | |
13,089
| | | | |
16,412
| | | | | |
Deferred income taxes
| | | | | | |
(9,376
|
)
| | | |
(13,711
|
)
| | | | |
Amortization of share-based awards
| | | | | |
|
(2,848
|
)
| | |
|
(2,500
|
)
| | | | |
EBITDA
| | | | | |
$
|
94,223
|
| | |
$
|
95,795
|
| | | | | | | | | | | | | | | | | | |
|
(b) The table below reconciles the calculation of (i) net income and
(ii) net income per share on a basic and diluted basis from the amounts
reported in accordance with GAAP to such amounts before giving effect to
acquisition-related and Elizabeth Arden repositioning costs. This
disclosure is being provided for comparability purposes because we
believe it is meaningful to our investors and other interested parties
to understand the Company's operating performance on a consistent basis
without regard to the effect of acquisition-related and Elizabeth Arden
repositioning costs. The presentation in the table below of the non-GAAP
information titled "Net income as adjusted" and "Net income per basic
and diluted share as adjusted" is not meant to be considered in
isolation or as a substitute for net income or net income per basic and
diluted share prepared in accordance with GAAP.
|
|
|
| |
|
| | | | (In thousands, except per share data) | | | | Three Months Ended | | | Six Months Ended | | | | | | December 31, |
| December 31, | | | December 31, |
| December 31, | | | | | | 2012 | | 2011 | | | 2012 | | 2011 | | | | | | | | | | | | | |
| Gross Profit: | | | | | | | | | | | | | |
Gross Profit as reported
| | | |
$
|
236,466
| |
$
|
217,313
| | |
$
|
383,865
| |
$
|
359,749
| |
Acquisition-related and Elizabeth Arden repositioning costs
(c)
| | | |
|
5,432
| |
|
--
| | |
|
20,152
| |
|
--
| | |
Gross Profit as adjusted
| | | |
$
|
241,898
| |
$
|
217,313
| | |
$
|
404,017
| |
$
|
359,749
| | | | | | | | | | | | | |
| Net Income Per Basic Share: | | | | | | | | | | | | | |
Net income per basic share as reported
| | | |
$
|
1.51
| |
$
|
1.46
| | |
$
|
1.59
| |
$
|
1.78
| |
Acquisition-related and Elizabeth Arden repositioning costs,
net of tax (c) (d)
| | | |
|
0.11
| |
|
--
| | |
|
0.49
| |
|
--
| | |
Net income per basic as adjusted
| | | |
$
|
1.62
| |
$
|
1.46
| | |
$
|
2.08
| |
$
|
1.78
| | | | | | | | | | | | | |
| Net Income Per Diluted Share: | | | | | | | | | | | | | |
Net income per diluted share as reported
| | | |
$
|
1.47
| |
$
|
1.42
| | |
$
|
1.54
| |
$
|
1.73
| |
Acquisition-related and Elizabeth Arden repositioning costs,
net of tax (c) (d)
| | | |
|
0.11
| |
|
--
| | |
|
0.48
| |
|
--
| | |
Net income per diluted share as adjusted
| | | |
$
|
1.58
| |
$
|
1.42
| | |
$
|
2.02
| |
$
|
1.73
| | | | | | | | | | | | | | | | | |
|
(c) For the three months ended December 31, 2012, gross profit and net
income include $1.9 million (pre-tax) of inventory–related costs
primarily for inventory purchased by us from New Wave Fragrances LLC and
Give Back Brands LLC prior to the fragrance license acquisitions from
those companies and $3.6 million (pre-tax) of costs related to the
repositioning of the Elizabeth Arden brand. In addition, net income
includes $0.3 million (pre-tax) of expenses related to the repositioning
of the Elizabeth Arden brand that were recorded in selling, general and
administrative expenses. For the six months ended December 31, 2012,
gross profit and net income include $13.2 million (pre-tax) of
inventory–related costs ($6.4 million of which did not required the use
of cash in the current period) primarily for inventory purchased by us
from New Wave Fragrances LLC and Give Back Brands LLC prior to the
fragrance license acquisitions from those companies and $7.0 million
(pre-tax) of costs related to the repositioning of the Elizabeth Arden
brand. In addition, net income includes $0.3 million (pre-tax) in
transition costs associated with the New Wave Fragrances LLC and Give
Back Brands LLC acquisitions and $0.4 million (pre-tax) of expenses
related to the repositioning of the Elizabeth Arden brand that were
recorded in selling, general and administrative expenses.
(d) Our effective tax rate on a reported basis, which is calculated as a
percentage of income before income taxes, was 22.0% and 21.8% for the
three and six months ended December 31, 2012, respectively. On a
reported basis, for the three and six months ended December 31, 2011,
our effective tax rate was 24.3% and 24.1%, respectively. On an adjusted
basis, for both the three and six months ended December 31, 2012, our
effective tax rate was 24.0%.
|
| SEGMENT NET SALES | |
|
The table below is a comparative summary of our net sales by
reportable segment for the three and six months ended December 31,
2012 and 2011:
|
|
|
| |
|
| |
|
| |
|
| | | | (In thousands) | | | Three Months Ended | | | % Increase (Decrease) | | | Six Months Ended | | | % Increase (Decrease) | | | | | December 31, 2012 |
| December 31, 2011 | | | GAAP |
| Constant Rates (e) | | | December 31, 2012 |
| December 31, 2011 | | | GAAP |
| Constant Rates (e) | | |
Segment Net Sales
| | | |
| | | | |
| | | | |
| | | | |
| | | |
North America
| | |
$
|
311,077
| |
$
|
287,095
| | |
8.4
|
%
| |
8.2
|
%
| | |
$
|
542,634
| |
$
|
480,061
| | |
13.0
|
%
| |
13.0
|
%
| | |
International
| | |
|
156,842
|
|
|
142,831
| | |
9.8
|
%
|
|
11.0
|
%
| | |
|
269,826
|
|
|
253,399
| | |
6.5
|
%
|
|
10.1
|
%
| | | | | | | | | | | | | | | | | | | | | | |
| |
Total
| | |
$
|
467,919
| |
$
|
429,926
| | |
8.8
|
%
| |
9.2
|
%
| | |
$
|
812,460
| |
$
|
733,460
| | |
10.8
|
%
| |
12.0
|
%
| |
|
| PRODUCT CATEGORY NET SALES | |
| |
The table below is a comparative summary of our net sales by product
category for the three and six months ended December 31, 2012 and
2011:
|
|
| |
| |
| |
| | | | (In thousands) | | Three Months Ended | | % Increase (Decrease) | | Six Months Ended | | % Increase (Decrease) | | | | December 31, 2012 |
| December 31, 2011 | | GAAP |
| Constant Rates (e) | | December 31, 2012 |
| December 31, 2011 | | GAAP |
| Constant Rates (e) | |
Product Category Net Sales:
| | |
| | | |
| | | |
| | | |
| | |
Elizabeth Arden Brand
| |
$
|
147,957
| |
$
|
143,568
| |
3.1
|
%
| |
3.8
|
%
| |
$
|
256,436
| |
$
|
257,866
| |
(0.6
|
)%
| |
1.7
|
%
| |
Celebrity, Lifestyle, Designer and Other
Fragrances
| |
|
319,962
|
|
|
286,358
| |
11.7
|
%
|
|
11.9
|
%
| |
|
556,024
|
|
|
475,594
| |
16.9
|
%
|
|
17.6
|
%
| | |
Total
| |
$
|
467,919
| |
$
|
429,926
| |
8.8
|
%
| |
9.2
|
%
| |
$
|
812,460
| |
$
|
733,460
| |
10.8
|
%
| |
12.0
|
%
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|
(e) Constant currency information compares results between periods
assuming exchange rates had remained constant period-over-period and
excludes gains and losses from foreign currency contracts in all
periods. We calculate constant currency information by translating
current-period results using prior-year GAAP foreign currency exchange
rates. The gains and/or losses from foreign currency contracts were not
material for all periods presented.
|
| |
| ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEET DATA
(Unaudited)
| | |
|
|
| |
|
| |
|
| | | | (In thousands) | | | | December 31, 2012 | | | June 30, 2012 | | | December 31, 2011 | | |
Cash
| | | |
$
|
46,003
| | |
$
|
59,080
| | |
$
|
62,340
| | |
Accounts Receivable, Net
| | | | |
288,479
| | | |
188,141
| | | |
216,877
| | |
Inventories
| | | | |
322,835
| | | |
291,987
| | | |
264,632
| | |
Property and Equipment, Net
| | | | |
91,769
| | | |
89,438
| | | |
78,981
| | |
Exclusive Brand Licenses, Trademarks and Intangibles, Net
| | | | |
305,598
| | | |
314,502
| | | |
224,028
| | |
Goodwill
| | | | |
21,054
| | | |
21,054
| | | |
21,054
| | |
Total Assets
| | | | |
1,168,683
| | | |
1,066,754
| | | |
954,736
| | |
Short-Term Debt
| | | | |
103,500
| | | |
89,200
| | | |
-
| | |
Current Liabilities
| | | | |
334,058
| | | |
278,679
| | | |
212,047
| | |
Long-Term Liabilities
| | | | |
295,686
| | | |
306,348
| | | |
267,406
| | |
Long-Term Debt
| | | | |
250,000
| | | |
250,000
| | | |
250,000
| | |
Shareholders' Equity
| | | | |
538,939
| | | |
481,727
| | | |
475,283
| | |
Working Capital
| | | | |
392,422
| | | |
345,818
| | | |
402,445
| |
|
|
|
|
| |
|
| | | | | | SUPPLEMENTARY CASH FLOW INFORMATION
(Unaudited)
(In thousands) | | | | | | | | |
|
|
|
|
| | | | | | | | | | | | | | | Six Months Ended | | | | | | | | | | | | | | December 31, 2012 |
|
|
| December 31, 2011 | | | | | | | | | | | | | | | | | | | | |
| | | | |
Net cash (used in) provided by operating activities
| | | | | |
$
|
(10,888
|
)
| | | |
$
|
49,169
| | | | | | | | |
Net cash used in investing activities
| | | | | | |
(27,072
|
)
| | | | |
(52,990
|
)
| | | | | | | |
Net cash provided by financing activities
| | | | | | |
24,816
| | | | | |
9,164
| | | | | | | | |
Net (decrease) increase in cash and cash equivalents
| | | | | | |
(13,077
|
)
| | | | |
3,490
| | | | | | | | | | | | | | | | | | | | | |
|
In connection with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Elizabeth Arden, Inc. is hereby providing
cautionary statements identifying important factors that could cause our
actual results to differ materially from those projected in
forward-looking statements (as defined in such act). Any statements that
are not historical facts and that express, or involve discussions as to,
expectations, beliefs, plans, objectives, assumptions or future events
or performance (often, but not always, indicated through the use of
words or phrases such as "will likely result," "are expected to," "will
continue," "is anticipated," "should," "estimated," "intends," "plans,"
"believes" and "projects") may be forward-looking and may involve
estimates and uncertainties which could cause actual results to differ
materially from those expressed in the forward-looking statements. These
statements include, but are not limited to, our guidance and
expectations regarding net sales, earnings, gross margins, operating
cash flow and returns on invested capital. In addition, any such
statements are qualified in their entirety by reference to, and are
accompanied by, the following key factors that have a direct bearing on
our results of operations:
|
*
|
|
factors affecting our relationships with our customers or our
customers' businesses, including the absence of contracts with
customers, our customers' financial condition, and changes in the
retail, fragrance and cosmetic industries, such as the consolidation
of retailers and the associated closing of retail doors as well as
retailer inventory control practices, including, but not limited to,
levels of inventory carried at point of sale and practices used to
control inventory shrinkage;
| |
*
| |
risks of international operations, including foreign currency
fluctuations, hedging activities, economic and political
consequences of terrorist attacks, disruptions in travel,
unfavorable changes in U.S. or international laws or regulations,
diseases and pandemics, and political instability in certain regions
of the world;
| |
*
| |
our reliance on license agreements with third parties for the rights
to sell many of our prestige fragrance brands;
| |
*
| |
our reliance on third-party manufacturers for substantially all of
our owned and licensed products and our absence of contracts with
suppliers of distributed brands and components for manufacturing of
owned and licensed brands;
| |
*
| |
delays in shipments, inventory shortages and higher supply chain
costs due to the loss of or disruption in our distribution
facilities or at key third party manufacturing or fulfillment
facilities that manufacture or provide logistic services for our
products;
| |
*
| |
our ability to respond in a timely manner to changing consumer
preferences and purchasing patterns and other international and
domestic conditions and events that impact retailer and/or consumer
confidence and demand, such as domestic or global recessions or
economic uncertainty;
| |
*
| |
our ability to protect our intellectual property rights;
| |
*
| |
the success, or changes in the timing or scope, of our new product
launches, advertising and merchandising programs;
| |
*
| |
the quality, safety and efficacy of our products;
| |
*
| |
the impact of competitive products and pricing;
| |
*
| |
our ability to (i) implement our growth strategy and acquire or
license additional brands or secure additional distribution
arrangements, (ii) successfully and cost-effectively integrate
acquired businesses or new brands, and (iii) finance our growth
strategy and our working capital requirements;
| |
*
| |
our level of indebtedness, our ability to realize sufficient cash
flows from operations to meet our debt service obligations and
working capital requirements, and restrictive covenants in our
revolving credit facility, term loan and the indenture for our 7
3/8% senior notes;
| |
*
| |
changes in product mix to less profitable products;
| |
*
| |
the retention and availability of key personnel;
| |
*
| |
changes in the legal, regulatory and political environment that
impact, or will impact, our business, including changes to customs
or trade regulations, laws or regulations relating to ingredients or
other chemicals or raw materials contained in products or packaging,
or accounting standards or critical accounting estimates;
| |
*
| |
the success of our global Elizabeth Arden brand repositioning
efforts;
| |
*
| |
the impact of tax audits, including the ultimate outcome of the
pending Internal Revenue Service examination of our U.S. federal tax
returns for the fiscal years ended June 30, 2008 and June 30, 2009,
changes in tax laws or tax rates, and our ability to utilize our
deferred tax assets;
| |
*
| |
our ability to effectively implement, manage and maintain our global
information systems and maintain the security of our confidential
data and our employees' and customers' personal information;
| |
*
| |
our reliance on third parties for certain outsourced business
services, including information technology operations and employee
benefit plan administration;
| |
*
| |
the potential for significant impairment charges relating to our
trademarks, goodwill or other intangible assets that could result
from a number of factors, including downward pressure on our stock
price; and
| |
*
| |
other unanticipated risks and uncertainties.
| | |
|
We caution that the factors described herein could cause actual results
to differ materially from those expressed in any forward-looking
statements we make and that investors should not place undue reliance on
any such forward-looking statements. Further, any forward-looking
statement speaks only as of the date on which such statement is made,
and we undertake no obligation to update any forward-looking statement
to reflect events or circumstances after the date on which such
statement is made or to reflect the occurrence of anticipated or
unanticipated events or circumstances. New factors emerge from time to
time, and it is not possible for us to predict all of such factors.
Further, we cannot assess the impact of each such factor on our results
of operations or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking statements. This press release is
qualified in its entirety by the cautionary statements and risk factor
disclosure contained in our Securities and Exchange Commission filings,
including our Annual Report on Form 10-K for the year ended June 30,
2012.
Contacts:
Elizabeth Arden, Inc. Marcey Becker, Senior Vice President, Finance or Investor/Press
Contact: Integrated Corporate Relations Allison Malkin/Michael
Fox, 203-682-8200
Source: Elizabeth Arden, Inc.
|